SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Market Gems:Stocks w/Strong Earnings and High Tech. Rank -- Ignore unavailable to you. Want to Upgrade?

To: debra vogt who wrote (92017)4/6/2000 2:17:00 PM
From: Andrew G.  Read Replies (1) | Respond to of 120523
 
MAXY, yes, I'm familiar. Read this:
thestreet.com

" Zaffaroni has co-founded four billion-dollar biotechnology companies and, in his late 70s, continues to create wealth for shareholders at a rate that few, if any, peers can match. "
"Zaffaroni's latest two inventions -- Maxygen (MAXY:Nasdaq - news - boards)
and Symyx Technologies (SMMX:Nasdaq - news - boards) -- could ultimately be the best fruits of a sturdy family tree."

Maxy gapped up very strongly this morning and is pulling back.
It may actually be a good buy here if the biotechs rise again tomorrow.

So many to choose from and so little time to be choosy.



To: debra vogt who wrote (92017)4/6/2000 2:21:00 PM
From: debra vogt  Respond to of 120523
 
AMT, CLNT and UCOMA:

AMT and CLNT held up relatively well during the recent downdraft. CLNT is trading at a new 52 wk high today. Also another long-termer for me: UCOMA is off substantially from it's highs, is having a nice recovery today.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News